Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
NCT06980649

Study of BHV-1300 in Graves' Disease

Led by Biohaven Therapeutics Ltd. · Updated on 2026-05-13

15

Participants Needed

17

Research Sites

105 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves' Disease and to explore its effect on disease-specific biomarkers.

CONDITIONS

Official Title

Study of BHV-1300 in Graves' Disease

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must have serologically confirmed Graves' Disease
  • Age between 18 and 65 years
Not Eligible

You will not qualify if you...

  • History of hyperthyroidism not caused by Graves' Disease (such as toxic adenoma or toxic multinodular goiter)
  • History of thyroid storm within six weeks before the baseline visit
  • Previous treatment with radioactive iodine
  • Previous thyroid surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 17 locations

1

Site-103

South Gate, California, United States, 90280

Actively Recruiting

2

Site-100

Miami, Florida, United States, 33126

Actively Recruiting

3

Site-104

Columbus, Georgia, United States, 31904

Actively Recruiting

4

Site-108

Greenville, North Carolina, United States, 27834

Not Yet Recruiting

5

Site-110

Canton, Ohio, United States, 44718

Actively Recruiting

6

Site-107

Memphis, Tennessee, United States, 38119

Actively Recruiting

7

Site-109

Dallas, Texas, United States, 75246

Not Yet Recruiting

8

Site-106

Houston, Texas, United States, 77054

Actively Recruiting

9

Site-101

Houston, Texas, United States, 77095

Actively Recruiting

10

Site-105

Shavano Park, Texas, United States, 78231

Actively Recruiting

11

Site-004

Fitzroy, Australia, 3065

Actively Recruiting

12

Site-001

Kotara, Australia, 2289

Actively Recruiting

13

Site-003

Melbourne, Australia, 3128

Actively Recruiting

14

Site-010

Oaklands Park, Australia, 5046

Actively Recruiting

15

Site-008

Parkville, Australia, 3050

Actively Recruiting

16

Site-006

St Leonards, Australia, 2065

Actively Recruiting

17

Site-002

Torquay, Australia, 3228

Actively Recruiting

Loading map...

Research Team

C

Chief Medical Officer

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study of BHV-1300 in Graves' Disease | DecenTrialz